A new review was published in , Volume 16, on March 13, 2025, titled "Signaling pathway dysregulation in breast cancer." ...

Patients undergoing BRAF/MEK inhibitor therapy for melanoma more commonly experience VKH-like uveitis compared with other malignancy types.

Researchers are testing a new combination drug therapy that could both treat and prevent melanoma metastasis, or spreading ...

A federally funded research team led by Sheri Holmen, PhD, investigator at Huntsman Cancer Institute and professor in the ...

Conference taking place on March 27-29, 2025 in New Orleans ---- CAGLA NeauxCancer Conference is a leading global forum in oncology --MIAMI, ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, ...

This drug, initially developed for cancer treatment, inhibits the MEK protein, which is overactivated in the cells of children with Noonan syndrome. It is this overactivation that causes ...

Dogs that have oral squamous cell carcinomas often need surgery that disfigures their jaws and lower their quality of ...

Holmen and her research team found that inhibiting the enzyme FAK in combination with an inhibitor of RAF and MEK—which targets another cellular pathway that regulates cancer cell growth—was effective ...